Medicare Enrolled
Dr. Zeeshan Danawala, M.D.
Urology Physician · Shenandoah, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Danawala from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Danawala?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Danawala
Dr. Zeeshan Danawala is an urology physician in Shenandoah, TX, with 15 years of NPI registration. Based on federal Medicare data, Dr. Danawala performed 3,286 Medicare services across 1,479 unique beneficiaries.
Between the years covered by Open Payments, Dr. Danawala received a total of $5,503 from 60 pharmaceutical and/or device companies across 214 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Danawala is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 15 years in practice
▲ Top 36% volume in TX
$5,503 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,286
Medicare services
Top 36% in TX for urology physician
1,479
Unique beneficiaries
$48
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~219 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Infectious disease DNA/RNA test A laboratory test that uses a specific technique to detect the genetic material of an organism. This method amplifies the target DNA or RNA to identify the presence of the organism. |
806 | $34 | $80 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
501 | $3 | $20 |
| Yeast/candida DNA test A laboratory test that uses an amplified probe technique to detect the presence of Candida species, a type of yeast, in a patient sample. |
308 | $34 | $80 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
288 | $88 | $150 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
245 | $62 | $105 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
152 | $8 | $100 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
120 | $16 | $80 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 108 | $135 | $882 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
69 | $111 | $245 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
65 | $55 | $250 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
64 | $179 | $425 |
| Staphylococcus aureus DNA test A laboratory test that uses DNA amplification to detect the presence of Staphylococcus aureus bacteria in a sample. |
62 | $34 | $80 |
| MRSA nucleic acid detection test A laboratory test that uses amplified probe techniques to detect the genetic material of methicillin-resistant Staphylococcus aureus (MRSA) bacteria. |
62 | $34 | $80 |
| Strep A nucleic acid amplification test A laboratory test that uses nucleic acid amplification to detect the presence of Group A Streptococcus bacteria. This method identifies the genetic material of the bacteria to determine if an infection is present. |
62 | $34 | $80 |
| Group B Strep DNA test A laboratory test that uses DNA amplification to detect the presence of Group B Streptococcus bacteria. |
62 | $34 | $80 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
49 | $100 | $250 |
| Abdominal X-ray, 1 view An X-ray image of the abdomen taken from a single angle to visualize internal structures. |
43 | $22 | $75 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
41 | $44 | $150 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
35 | $73 | $180 |
| Nucleic acid test for multiple organisms A laboratory test that uses amplified probe techniques to detect the genetic material of multiple organisms in a sample. |
31 | $69 | $150 |
| VRE nucleic acid detection test A laboratory test that uses amplified probe techniques to detect vancomycin-resistant Enterococcus (VRE) DNA in a patient sample. |
28 | $34 | $80 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
23 | $19 | $150 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
18 | $311 | $4,000 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
18 | $26 | $57 |
| Transurethral prostate removal with electrocautery This procedure involves removing the prostate gland through the urethra using an endoscope and an electrocautery knife to control bleeding. |
14 | $539 | $2,300 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
12 | $124 | $300 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.5% high complexity
5.9% medium
93.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$5,503
Total received (2018-2024)
Avg $786/year across 7 years
Top 36% in TX for urology physician
60
Companies
214
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,347 (97.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$155 (2.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$533
2023
$646
2022
$1,117
2021
$591
2020
$215
2019
$661
2018
$1,739
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
NeoTract Inc.
$872
Astellas Pharma US Inc
$699
Teleflex LLC
$317
Boston Scientific Corporation
$316
Agiliti Surgical, Inc.
$258
ABBVIE INC.
$251
Janssen Biotech, Inc.
$194
Avadel Specialty Pharmaceuticals, LLC
$160
PFIZER INC.
$152
AstraZeneca Pharmaceuticals LP
$132
AbbVie Inc.
$110
Sumitomo Pharma America, Inc.
$101
Janssen Products, LP
$100
Endo Pharmaceuticals Inc.
$93
C. R. Bard, Inc. & Subsidiaries
$93
Antares Pharma, Inc.
$92
Allergan Inc.
$85
Blue Earth Diagnostics Limited
$72
Rochester Medical Corporation
$70
Verity Pharmaceuticals Inc.
$68
Dendreon Pharmaceuticals LLC
$66
Allergan, Inc.
$63
Medtronic, Inc.
$60
Axonics, Inc.
$59
Bayer HealthCare Pharmaceuticals Inc.
$54
BioTissue Holdings, Inc.
$53
AbbVie, Inc.
$53
MEDIVATION FIELD SOLUTIONS LLC
$50
Myovant Sciences Inc.
$46
Merck Sharp & Dohme LLC
$46
Ferring Pharmaceuticals Inc.
$42
ConvaTec Inc.
$42
Retrophin, Inc.
$39
UROVANT SCIENCES INC
$38
Cook Medical LLC
$36
Palette Life Sciences, Inc.
$35
Hollister Incorporated
$33
BIOTISSUE HOLDINGS, INC.
$33
Olympus America Inc.
$30
Laborie Medical Technologies Corp.
$28
Clinical Laserthermia Systems Americas Inc.
$25
TherapeuticsMD, Inc.
$24
Progenics Pharmaceuticals, Inc.
$24
Lantheus Medical Imaging, Inc.
$23
TISSUETECH, INC.
$23
PROCEPT BioRobotics Corporation
$22
BOSTON SCIENTIFIC CORPORATION
$22
BAXTER HEALTHCARE
$20
COLOPLAST CORP
$19
180 Medical, Inc.
$19
BIOPROTECT MEDICAL, INC.
$18
Baxter Healthcare
$16
Bayer Healthcare Pharmaceuticals Inc.
$16
Takeda Pharmaceuticals U.S.A., Inc.
$16
Novartis Pharmaceuticals Corporation
$16
Coloplast Corp
$15
Accord Healthcare, Inc.
$15
Profound Medical Corp.
$14
Levita Magnetics International Corp
$14
Mission Pharmacal Company
$1
Top 3 companies account for 34.3% of total payments
Associated products mentioned in payments ›
(815) Thiola · AQUABEAM SYSTEM · Androgel · Axonics · Axonics r-SNM System · Axumin · BIOPROTECT BALLOON IMPLANT SYSTEM · BOTOX · BOTOX THERAPEUTIC · Bard Urinary Drainage Bag · CAMCEVI · COOK MEDICAL LASERS · ERLEADA · Erleada · FIRMAGON · FLEXIVA · GEMTESA · GENERAL BPH · GENERAL ONCOLOGY · GENERAL - KIDNEY STONE DISEASE · GENERAL BPH · General - Kidney Stone Disease · GentleCath · IMVEXXY · INTERSTIM · Infyna Chic · KEYTRUDA · LOFRIC · LUPRON DEPOT · LYNPARZA · Lupron Depot · MOBILE LASER UNIT · MYRBETRIQ · Magnetic Surgery · Myrbetriq · NATPARA (PARATHYROID HORMONE) · NEOX · NOCDURNA · Noctiva · Nubeqa · ORGOVYX · Olympus Laser Devices · PLUVICTO · POSLUMA · PROVENGE · PYLARIFY · Quadramet · RESONANCE · REZUM · Sonablate · Sonablate HIFU · SpaceOAR VUE System - 10mL · TISSEEL · TOVIAZ · Titan · Trelstar · URIBEL TABS · UROLIFT · UroLift · UroLift System · Veozah · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · ZYTIGA · rezum Generator
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $167 per 100 Medicare services performed
Geographic Context
Urology physicians within 10 mi
41
Per 100K population
6.3
County median income
$97,266
Nearest hospital
ST LUKE'S THE WOODLANDS HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Danawala is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 15 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Danawala experienced with infectious disease dna/rna test?
Based on Medicare claims data, Dr. Danawala performed 806 infectious disease dna/rna test services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Danawala receive payments from pharmaceutical companies?
Yes. Dr. Danawala received a total of $5,503 from 60 companies across 214 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Danawala's costs compare to other urology physicians in Shenandoah?
Dr. Danawala's average Medicare payment per service is $48. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Danawala) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Shenandoah
Browse urology physicians in Shenandoah ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in TX
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in TX
Which TX urology physicians receive the most from drug and device companies.
By company
NeoTract Inc. Payments to Doctors
See all physicians who received payments from NeoTract Inc.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Teleflex LLC Payments to Doctors
See all physicians who received payments from Teleflex LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology